(2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid
C30H35NO14 — CID 122681338
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid
(2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid (PubChem CID 122681338) has the molecular formula C30H35NO14 and a molecular weight of 633.60 g/mol. Its IUPAC name is (2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid.
Molecular Properties
| Compound Name | (2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid |
|---|---|
| PubChem CID | 122681338 |
| Molecular Formula | C30H35NO14 |
| Molecular Weight | 633.60 g/mol |
| Exact Mass | 633.21 |
| IUPAC Name | (2R)-2-[(2S)-2-[(3S)-3-hydroxy-4-[[(1S,2S,6R,14R)-2-hydroxy-9-(hydroxymethyl)-15-methyl-7-oxa-15-azapentacyclo[10.6.1.01,6.02,14.08,19]nonadeca-4,8,10,12(19)-tetraen-5-yl]oxy]-4-oxobutanoyl]oxypropanoyl]oxybutanedioic acid |
| SMILES | C[C@H](OC(=O)C[C@H](O)C(=O)OC1=CC[C@@]2(O)[C@H]3Cc4ccc(CO)c5c4[C@@]2(CCCN3C)[C@H]1O5)C(=O)O[C@H](CC(=O)O)C(=O)O |
| InChI | InChI=1S/C30H35NO14/c1-14(27(39)44-19(26(37)38)12-21(34)35)42-22(36)11-17(33)28(40)43-18-6-8-30(41)20-10-15-4-5-16(13-32)24-23(15)29(30,25(18)45-24)7-3-9-31(20)2/h4-6,14,17,19-20,25,32-33,41H,3,7-13H2,1-2H3,(H,34,35)(H,37,38)/t14-,17-,19+,20+,25-,29-,30+/m0/s1 |
| InChIKey | SBEJVZBRCNNMJY-RVBGUBPISA-N |
| XLogP | -0.46 |
| TPSA | 226.66 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 633.60 |
| LogP ≤ 5 | -0.46 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122681338 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.